Neonc Technologies (NTHI) Competitors

$4.99 +0.85 (+20.53%)

Closing price 04:00 PM Eastern

Extended Trading

$5.06 +0.07 (+1.32%)

As of 05:40 PM Eastern

NTHI vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Neonc Technologies stock or one of its competitors? The main competitors of Neonc Technologies include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Neonc Technologies compare to Ainos?

Ainos (NASDAQ:AIMDW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

: Company Net Margins Return on Equity Return on Assets
Ainos N/A N/A N/A
Neonc Technologies N/A N/A N/A
: Neonc Technologies has a consensus target price of $15.00, indicating a potential upside of 200.60%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Neonc Technologies is more favorable than Ainos.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ainos $124.16K N/A N/A N/A N/A
Neonc Technologies $39.99K N/A N/A N/A N/A
: In the previous week, Neonc Technologies had 4 more articles in the media than Ainos. MarketBeat recorded 4 mentions for Neonc Technologies and 0 mentions for Ainos. Neonc Technologies' average media sentiment score of 1.30 beat Ainos' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.
Company Overall Sentiment
Ainos Neutral
Neonc Technologies Positive

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$124.16K	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Ainos	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Ainos on 5 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

: Company Net Margins Return on Equity Return on Assets
Alvotech N/A N/A N/A
Neonc Technologies N/A N/A N/A
: Neonc Technologies has a consensus price target of $15.00, suggesting a potential upside of 200.60%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Alvotech.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alvotech
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alvotech $586.32M N/A N/A N/A N/A
Neonc Technologies $39.99K N/A N/A N/A N/A
: In the previous week, Neonc Technologies had 4 more articles in the media than Alvotech. MarketBeat recorded 4 mentions for Neonc Technologies and 0 mentions for Alvotech. Neonc Technologies' average media sentiment score of 1.30 beat Alvotech's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.
Company Overall Sentiment
Alvotech Neutral
Neonc Technologies Positive

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alvotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Alvotech	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Alvotech on 5 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Aravive?

Aravive (NASDAQ:ARAV) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

: Company Net Margins Return on Equity Return on Assets
Aravive N/A N/A N/A
Neonc Technologies N/A N/A N/A
: Neonc Technologies has lower revenue, but higher earnings than Aravive.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aravive $6.99M 0.42 -$66.21M -$0.90 N/A
Neonc Technologies $39.99K N/A N/A N/A N/A
: Neonc Technologies has a consensus price target of $15.00, suggesting a potential upside of 200.60%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Neonc Technologies is more favorable than Aravive.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aravive
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: 35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: In the previous week, Neonc Technologies had 4 more articles in the media than Aravive. MarketBeat recorded 4 mentions for Neonc Technologies and 0 mentions for Aravive. Neonc Technologies' average media sentiment score of 1.30 beat Aravive's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.
Company Overall Sentiment
Aravive Neutral
Neonc Technologies Positive

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	$6.99M	0.42	-$66.21M	-$0.90	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aravive	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Overall Sentiment
Aravive	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Aravive on 5 of the 8 factors compared between the two stocks.

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

: Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
Neonc Technologies N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
Neonc Technologies $39.99K N/A N/A N/A N/A
: Neonc Technologies has a consensus price target of $15.00, suggesting a potential upside of 200.60%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Neonc Technologies is more favorable than Atlantic Coastal Acquisition Corp. II.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atlantic Coastal Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, Neonc Technologies had 4 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 4 mentions for Neonc Technologies and 0 mentions for Atlantic Coastal Acquisition Corp. II. Neonc Technologies' average media sentiment score of 1.30 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Neonc Technologies Positive

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Atlantic Coastal Acquisition Corp. II	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Atlantic Coastal Acquisition Corp. II on 6 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Avidity Biosciences?

Neonc Technologies (NASDAQ:NTHI) and Avidity Biosciences (NASDAQ:RNA) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

: Neonc Technologies currently has a consensus price target of $15.00, suggesting a potential upside of 200.60%. Avidity Biosciences has a consensus price target of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Avidity Biosciences is more favorable than Neonc Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Avidity Biosciences
1 Sell rating(s)

12 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
2.32
: In the previous week, Neonc Technologies had 3 more articles in the media than Avidity Biosciences. MarketBeat recorded 4 mentions for Neonc Technologies and 1 mentions for Avidity Biosciences. Neonc Technologies' average media sentiment score of 1.30 beat Avidity Biosciences' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.
Company Overall Sentiment
Neonc Technologies Positive
Avidity Biosciences Neutral
: Neonc Technologies has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Neonc Technologies' return on equity of 0.00% beat Avidity Biosciences' return on equity.
Company Net Margins Return on Equity Return on Assets
Neonc Technologies N/A N/A N/A
Avidity Biosciences -3,650.39% -44.92% -39.57%
: Neonc Technologies has higher earnings, but lower revenue than Avidity Biosciences.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Neonc Technologies $39.99K N/A N/A N/A N/A
Avidity Biosciences $18.62M N/A -$322.30M N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Avidity Biosciences	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.32

Company	Overall Sentiment
Neonc Technologies	Positive
Avidity Biosciences	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
Avidity Biosciences	-3,650.39%	-44.92%	-39.57%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A
Avidity Biosciences	$18.62M	N/A	-$322.30M	N/A	N/A

Summary

Neonc Technologies and Avidity Biosciences tied by winning 5 of the 10 factors compared between the two stocks.

Get Neonc Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTHI vs. The Competition

Export

Metric	Neonc Technologies	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	$889.47M	$4.21B	$11.87B
Dividend Yield	N/A	4.84%	5.61%	5.21%
P/E Ratio	N/A	1.71	23.40	28.47
Price / Sales	N/A	120.50	186.69	60.92
Price / Cash	N/A	20.07	52.82	36.52
Price / Book	N/A	7.60	38.31	6.67
Net Income	N/A	-$4.80M	$114.66M	$332.53M
7 Day Performance	15.78%	-0.05%	1.23%	2.01%
1 Month Performance	-16.13%	5.50%	5.54%	9.19%
1 Year Performance	14.45%	30.96%	18.68%	39.59%

Neonc Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTHI Neonc Technologies	3.5708 of 5 stars	$4.99 +20.5%	$15.00 +200.6%	N/A	$0.00	$39.99K	N/A	8	News Coverage Positive News Gap Up High Trading Volume
AIMDW Ainos	N/A	$0.08 +3.3%	N/A	N/A	$0.00	$124.16K	N/A	40
ALVOW Alvotech	N/A	$0.21 -17.9%	N/A	N/A	$0.00	$586.32M	N/A	4	Upcoming Earnings Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTHI) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neonc Technologies (NTHI) Competitors

NTHI vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

How does Neonc Technologies compare to Ainos?

Summary

How does Neonc Technologies compare to Alvotech?

Summary

How does Neonc Technologies compare to Aravive?

Summary

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Neonc Technologies compare to Avidity Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neonc Technologies (NTHI) Competitors

NTHI vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

How does Neonc Technologies compare to Ainos?

Summary

How does Neonc Technologies compare to Alvotech?

Summary

How does Neonc Technologies compare to Aravive?

Summary

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Neonc Technologies compare to Avidity Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools